Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-81 |
Sentence |
denotes |
Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. |
T1 |
0-81 |
Sentence |
denotes |
Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. |
T2 |
82-261 |
Sentence |
denotes |
Although corticosteroid therapy might be clinically beneficial for bronchiectasis, very little is known of its effects on the inflammatory and infective markers in bronchiectasis. |
T2 |
82-261 |
Sentence |
denotes |
Although corticosteroid therapy might be clinically beneficial for bronchiectasis, very little is known of its effects on the inflammatory and infective markers in bronchiectasis. |
T3 |
262-421 |
Sentence |
denotes |
We have therefore performed a double-blind, placebo-controlled study to evaluate the effects of a 4-wk administration of inhaled fluticasone in bronchiectasis. |
T3 |
262-421 |
Sentence |
denotes |
We have therefore performed a double-blind, placebo-controlled study to evaluate the effects of a 4-wk administration of inhaled fluticasone in bronchiectasis. |
T4 |
422-602 |
Sentence |
denotes |
Twenty-four patients (12 female; mean age 51 yr) were randomized into receiving either inhaled fluticasone (500 microgram twice daily) via the Accuhaler device (n = 12) or placebo. |
T4 |
422-602 |
Sentence |
denotes |
Twenty-four patients (12 female; mean age 51 yr) were randomized into receiving either inhaled fluticasone (500 microgram twice daily) via the Accuhaler device (n = 12) or placebo. |
T5 |
603-832 |
Sentence |
denotes |
At each visit, spirometry, 24-h sputum volume, sputum leukocyte density, bacterial densities, and concentrations of interleukin (IL)-1beta, IL-8, tumor necrosis factor-alpha (TNF-alpha), and leukotriene B4 (LTB4) were determined. |
T5 |
603-832 |
Sentence |
denotes |
At each visit, spirometry, 24-h sputum volume, sputum leukocyte density, bacterial densities, and concentrations of interleukin (IL)-1beta, IL-8, tumor necrosis factor-alpha (TNF-alpha), and leukotriene B4 (LTB4) were determined. |
T6 |
833-962 |
Sentence |
denotes |
There was a significant (p < 0.05) decrease in sputum leukocyte density and IL-1beta, IL-8, and LTB4 after fluticasone treatment. |
T6 |
833-962 |
Sentence |
denotes |
There was a significant (p < 0.05) decrease in sputum leukocyte density and IL-1beta, IL-8, and LTB4 after fluticasone treatment. |
T7 |
963-1046 |
Sentence |
denotes |
The fluticasone group had one and the placebo group three episodes of exacerbation. |
T7 |
963-1046 |
Sentence |
denotes |
The fluticasone group had one and the placebo group three episodes of exacerbation. |
T8 |
1047-1156 |
Sentence |
denotes |
There were no significant changes in spirometry (p > 0.05) or any reported adverse reactions in either group. |
T8 |
1047-1156 |
Sentence |
denotes |
There were no significant changes in spirometry (p > 0.05) or any reported adverse reactions in either group. |
T9 |
1157-1290 |
Sentence |
denotes |
The results of this study show that high-dose fluticasone is effective in reducing the sputum inflammatory indices in bronchiectasis. |
T9 |
1157-1290 |
Sentence |
denotes |
The results of this study show that high-dose fluticasone is effective in reducing the sputum inflammatory indices in bronchiectasis. |
T10 |
1291-1439 |
Sentence |
denotes |
Large-scale and long-term studies are indicated to evaluate the effects of inhaled steroid therapy on the inflammatory components in bronchiectasis. |
T10 |
1291-1439 |
Sentence |
denotes |
Large-scale and long-term studies are indicated to evaluate the effects of inhaled steroid therapy on the inflammatory components in bronchiectasis. |